Tri Locum Partners’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-77,048
| Closed | -$5.08M | – | 63 |
|
|
2023
Q1 | $5.08M | Sell |
77,048
-144,849
| -65% | -$9.55M | 1.55% | 23 |
|
|
2022
Q4 | $11.5M | Buy |
+221,897
| New | +$11.5M | 4.64% | 8 |
|
|
2022
Q1 | – | Sell |
-318,269
| Closed | -$15M | – | 41 |
|
|
2021
Q4 | $15M | Buy |
+318,269
| New | +$15M | 5.92% | 6 |
|
|
2021
Q1 | – | Sell |
-121,409
| Closed | -$6.95M | – | 33 |
|
|
2020
Q4 | $6.95M | Buy |
+121,409
| New | +$6.95M | 2.52% | 14 |
|